Saltar al contenido
Merck

Imidapril-induced eosinophilic pleurisy. Case report and review of the literature.

Respiration; international review of thoracic diseases (2005-08-10)
Hiromichi Yoshida, Ritsuko Hasegawa, Haruyuki Hayashi, Yasubumi Irie
RESUMEN

We describe an unusual case of a patient with eosinophilic pleurisy associated with long-term administration of imidapril, an angiotensin-converting enzyme inhibitor (ACEI). An 81-year-old woman who had been given imidapril for the treatment of essential hypertension was admitted to our hospital for investigation of persistent low-grade fever, dry cough and difficulty in breathing. Left-sided eosinophilic pleurisy was diagnosed based on eosinophilic pleural effusion and peripheral eosinophilia. Soon after administration of imidapril was discontinued, her clinical symptoms subsided, and there was improvement in both diagnostic imaging and laboratory findings. So far, to our knowledge, this is the first reported case in which ACEI induced eosinophilic pleurisy.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Imidapril hydrochloride, ≥98% (HPLC)